Randomized phase III trial comparing adjuvant oral UFT [tegafur/uracil]/LV [leucovorin; folinic acid] to 5-FU [fluorouracil]/l-LV in stage III colorectal cancer (JCOG-0205-MF)
Latest Information Update: 29 Sep 2016
Price :
$35 *
At a glance
- Drugs Folinic acid (Primary) ; Tegafur/uracil (Primary) ; Fluorouracil
- Indications Colon cancer; Colorectal cancer
- Focus Therapeutic Use
- 26 Mar 2013 New source identified and integrated (University Hospital Medical Information Network - Japan, C000000193).
- 05 Jun 2012 Final results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 15 Dec 2009 Actual patient number (1101) added as reported by ClinicalTrials.gov.